Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 5 of the 6 references it cites were found in a registry or an index.

Race-Based Therapeutics

Bloche, M. Gregg · 2004 · New England Journal of Medicine

Abstract

Are we moving into a new era of race-based therapeutics? The publication, in this issue of the Journal, of the African-American Heart Failure Trial (A-HeFT) (pages 2049–2057), a clinical trial of a medication intended for a single racial group, poses this awkward question. The study's most striking finding — that the addition of isosorbide dinitrate and hydralazine to conventional therapy for heart failure reduced relative one-year mortality by 43 percent among blacks — will provoke wide discussion. The trial's sponsor, NitroMed, which holds a patent on the fixed-dose combination of isosorbide dinitrate and hydralazine that was used, posits that heart . . .

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmp048271

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Research works printed but not linked: 1

  1. Kahn J, 2004, Yale J Health Policy Law Ethics, 4, 1

Cited by

See all 150

Metadata

Authors
Bloche, M. G.
Affiliations
Georgetown University (US)
Corresponding author
Bloche, M. Gregg
Venue
New England Journal of Medicine
Published
2004-11-11
Volume
351
Issue
20
Pages
2035-2037
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2135617416
Cited by
150
References
6
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 2 · 2012: 15
FWCI
9.82
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics
  • Social Sciences › Anthropology › Race, Genetics, and Society
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
racial medicine, heart failure, isosorbide dinitrate, hydralazine, fixed-dose combination, racial disparities in mortality, patent litigation
MeSH terms
Angiotensin-Converting Enzyme Inhibitors, Black or African American, Drug Combinations, Drug Industry, Drug Therapy, Combination, Enalapril, Heart Failure, Humans, Hydralazine, Isosorbide Dinitrate, Patents as Topic, Pharmacogenetics, United States, United States Food and Drug Administration, Vasodilator Agents, Drug Approval, Nitric Oxide Donors, Black People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.